Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

TRULICITY® (dulaglutide): Formulation

The formulation of Trulicity (dulaglutide) consists of dulaglutide 1.5 mg or dulaglutide 0.75 mg in a solution with several other components.

Detailed Information

Dulaglutide is a clear, colorless, and sterile solution.1 

Each 0.5 mL of dulaglutide solution contains 1.5 mg of dulaglutide or 0.75 mg of dulaglutide.1

Each single-dose pen contains 0.5 mL of solution and excipients in water for injection that includes

  • 0.07 mg citric acid anhydrous

  • 23.2 mg mannitol 

  • 0.10 mg polysorbate 80, and

  • 1.37 mg trisodium citrate dihydrate.1 

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

Reference

1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Date of Last Review: January 06, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical